Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Redefining Menopause Management: Addressing Gaps, Embracing Innovations, and Enhancing Outcomes : Episode 1
Understanding the Burden of Menopausal Vasomotor Symptoms
Panelists discuss how innovative neurokinin-targeted therapies for vasomotor symptoms can reshape menopause management and address unmet needs and improving patient outcomes while highlighting the importance of equity in treatment access.
Video content above is prompted by the following:
- Let’s begin by discussing the impact of VMS related to menopause and the large number of people affected. According to the SWAN[Study of Women’s Health Across the Nation] data, up to 80% of women experience these symptoms, with a median duration of 7.4 years. Additionally, most women describe the severity of their symptoms as moderate to severe. How does this compare to with the types of symptoms, severity, and duration that you’re seeing among the women in your practice?
- There also appears to be racial and ethnic differences, with Black women experiencing a higher prevalence, duration, and severity of VMS than women of other races or ethnicities. How do these differences impact your interactions with your patients?
Related Videos
Related Content
